Cefazolin

Cefazolin

SCHEMBL3894722

Cc1nnc(SCC2=C(C(=O)O)N3C(=O)C(NC(=O)Cn4cnnn4)[C@@H]3SC2)s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Cefazolin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 1.00
PTGS2 P35354 1/20 1.00
SLC22A6 Q4U2R8 1/20 1.00
SLC22A8 Q8TCC7 1/20 1.00
SLC22A11 Q9NSA0 1/20 1.00
MAPT P10636 9/20 0.86
TDP1 Q9NUW8 9/20 0.86
ABCC4 O15439 1/20 0.86
BLM P54132 1/20 0.86
CYP3A4 P08684 1/20 0.86
NFKB1 P19838 1/20 0.86
HSD17B10 Q99714 1/20 0.86
PTGS1 P23219 1/20 0.73
PDE4A P27815 1/20 0.73
KDR P35968 1/20 0.73
POLB P06746 9/20 0.71
ALDH1A1 P00352 4/20 0.69
MAPK1 P28482 1/20 0.69
KMT2A Q03164 3/20 0.68
MEN1 O00255 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefazolin SCHEMBL11031717 1.00 LMNA (1.00) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL3424683 1.00 LMNA (1.00) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL16072809 1.00 LMNA (1.00) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL2841 1.00 LMNA (1.00) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL2842 1.00 LMNA (1.00) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL4930576 1.00 LMNA (1.00) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL2219475 0.99 LMNA (0.98) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL40736 0.99 LMNA (0.98) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL6364010 0.99 LMNA (0.98) LMNAPTGS2SLC22A6SLC22A8SLC22A11
Cefazolin SCHEMBL29204288 0.99 LMNA (0.98) LMNAPTGS2SLC22A6SLC22A8SLC22A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4379739-A Electrolytic reduction of cephalosporin p-nitrobenzyl esters ELI LILLY AND COMPANY (US) 1983-04-12 US claimed
JP-59046291-A None JP disclosed
EP-0986565-B1 IMPROVED PRECIPITATION PROCESS OF 7-AMINOCEPHALOSPORANIC ACID (7-ACA) SANDOZ AG (CH) 2009-01-14 EP disclosed
EP-0060301-B1 PROCESS FOR PREPARING CEPHALOSPORIN COMPOUNDS Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1985-11-27 EP disclosed
JP-S5946291-A NOVEL PREPARATION OF CEPHAZOLIN AND ITS NON-TOXIC SALT TOUBISHI YAKUHIN KOGYO KK 1984-03-15 JP disclosed
US-4379739-A Electrolytic reduction of cephalosporin p-nitrobenzyl esters ELI LILLY AND COMPANY (US) 1983-04-12 US disclosed
EP-0060301-A1 PROCESS FOR PREPARING CEPHALOSPORIN COMPOUNDS Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-09-22 EP disclosed
US-4327211-A REACTING WITH 1,3,4-THIADIAZOLE THIOL ESTER OF 1H-TETRAZOLE ACETIC ACID ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1982-04-27 US disclosed
US-4314059-A Process for preparing cephalosporin compounds SHIBUYA CHISEI 1982-02-02 US disclosed
EP-0038626-A1 A process for electrolytic reduction of cephalosporin p-nitrobenzyl esters ELI LILLY AND COMPANY (US) 1981-10-28 EP disclosed
US-4144391-A REPLACING AN ACETOXY GROUP BY A SULFUR NUCLEOPHILE ELI LILLY AND COMPANY (US) 1979-03-13 US disclosed
US-4115645-A SODIUM SULFITE, SODIUM DITHIONITE ELI LILLY AND COMPANY (US) 1978-09-19 US disclosed
US-4029782-A LECITHIN, SURFACTANT, WATER, THICKENER ELI LILLY AND COMPANY (US) 1977-06-14 US disclosed
US-4028355-A Cephalosporin purification process SMITHKLINE CORPORATION (US) 1977-06-07 US disclosed
US-4002748-A Method of preparing sterile essentially amorphous cefazolin for reconstitution for parenteral administration ELI LILLY AND COMPANY (US) 1977-01-11 US disclosed
US-3979383-A Purification process for 7-aminocephalosporins ELI LILLY AND COMPANY (US) 1976-09-07 US disclosed
US-3976635-A Novel esterifying agents, and their production and use FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1976-08-24 US disclosed
US-3954745-A Process for preparing cefazolin ELI LILLY AND COMPANY (US) 1976-05-04 US disclosed
US-3943126-A Process for acylating a 7-aminocephalosporin ELI LILLY AND COMPANY (US) 1976-03-09 US disclosed
US-3932441-A MOLECULAR DISTILLATION DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1976-01-13 US disclosed